eGenesis logo

Principal Research Associate, Analytical Development

eGenesis

Cambridge, MAOnsitePosted 1 day ago$103,700 - $122,000/year
Full TimeSenior LevelResearch & ScientistBiotechnology
Original posting ↗

Summary

We are seeking a highly motivated Principal Research Associate to join the Analytical Development team. This is an opportunity to develop analytical methods supporting gene-edited xenotransplantation products in a dynamic environment focused on molecular and cellular engineering.

Job description

Position Summary

We are seeking a highly motivated Principal Research Associate to join the Analytical Development team. This is an opportunity to develop analytical methods supporting gene-edited xenotransplantation products in a dynamic environment focused on molecular and cellular engineering.

In this role, you will independently develop analytical assays from initial concept and feasibility through optimization, qualification, and transfer. Responsibilities include assessing transgene expression and biological function in genetically modified porcine cells, with a particular emphasis on developing robust, mechanism-relevant potency assays. The successful candidate will be expected to select appropriate assay formats and biological readouts, establish controls, understand critical assay variables, and solve complex development challenges with limited supervision.

The position involves significant hands-on cell culture, including the isolation, growth, and maintenance of porcine primary cells. Methods may include cell-based functional assays, flow cytometry, ELISA, and real-time PCR. This is a full-time, laboratory-based position suited for a proactive, rigorous, collaborative scientist who is comfortable building new methods where established procedures may not yet exist.

Primary Responsibilities

  • Independently develop expression and potency assays from the ground up, from assay concept and biological rationale through feasibility, optimization, and qualification.
  • Serve as the subject matter expert for assigned methods and define assay strategy, format, biological readout, controls, and system-suitability criteria.
  • Develop and optimize fit-for-purpose methods for transgene expression and product characterization, including flow cytometry, ELISA, real-time PCR, and cellular assays.
  • Evaluate assay performance, including precision, specificity, sensitivity, relative accuracy, range, robustness, and repeatability, as appropriate to the method and stage of development.
  • Independently troubleshoot assay failures, conduct root-cause investigations, interpret complex data, and recommend scientifically justified paths forward.
  • Culture, isolate, expand, characterize, and maintain mammalian primary cells and cell lines while controlling sources of biological variability.
  • Manage critical reagent and reference-material lifecycles, including cell banks, standards, antibodies, controls, inventory, and lot-bridging studies.
  • Partner with QC and cross-functional stakeholders on method transfer, assay alignment, and transfer-related troubleshooting.
  • Author and review development and qualification documents, maintain accurate laboratory records, communicate results and risks, and provide technical guidance to junior team members.

Basic Qualifications

  • B.S. or B.A. in cell biology, immunology, biomedical engineering, or a related scientific discipline with 6-8 years of relevant industry experience, or an M.S. with 4-6 years of relevant industry experience.
  • Demonstrated experience independently developing analytical methods from initial concept and feasibility through optimization, qualification, and implementation.
  • Hands-on experience developing, optimizing, and troubleshooting assays that measure biological activity or potency.
  • Expertise in mammalian cell culture and assay development using flow cytometry and ELISA, including control strategy and troubleshooting.
  • Experience designing controlled experiments, interpreting multivariable data, evaluating assay performance, and establishing fit-for-purpose controls and acceptance criteria.
  • Ability to independently manage laboratory work across concurrent projects, document and communicate scientific results clearly, and collaborate effectively across functions.

Preferred Qualifications

  • Direct experience developing cell-based potency assays, particularly with engineered primary cells, endothelial cells, immune-mediated mechanisms, or complex functional readouts.
  • Experience with analytical method qualification and transfer to a QC or regulated testing environment.
  • Experience establishing and monitoring critical reagent or cell-bank controls, including lot qualification and bridging studies.
  • Experience providing technical mentorship or guidance to research associates or junior scientists.

Requirements

  • B.S. or B.A. in cell biology, immunology, biomedical engineering, or a related scientific discipline with 6-8 years of relevant industry experience, or an M.S. with 4-6 years of relevant industry experience
  • Demonstrated experience independently developing analytical methods from initial concept and feasibility through optimization, qualification, and implementation
  • Hands-on experience developing, optimizing, and troubleshooting assays that measure biological activity or potency
  • Expertise in mammalian cell culture and assay development using flow cytometry and ELISA, including control strategy and troubleshooting
  • Experience designing controlled experiments, interpreting multivariable data, evaluating assay performance, and establishing fit-for-purpose controls and acceptance criteria
  • Ability to independently manage laboratory work across concurrent projects, document and communicate scientific results clearly, and collaborate effectively across functions

Company overview

eGenesis is a pioneering biotechnology company founded in 2015 and headquartered in Cambridge, Massachusetts, that is revolutionizing the field of organ transplantation through xenotransplantation. The company leverages its proprietary multiplex gene editing and genome engineering platform to develop human-compatible (HuCo) organs and cells, specifically focusing on addressing the global organ shortage crisis. eGenesis's EGEN Platform utilizes advanced CRISPR-based technologies to perform three classes of genetic modifications on porcine organs: eliminating endogenous retroviruses to prevent cross-species infection, knocking out porcine genes that trigger immune rejection, and inserting human genes to improve compatibility. The company has achieved significant milestones including the world's first successful transplant of a genetically engineered porcine kidney into a living patient in March 2024, followed by additional successful procedures. With lead programs in kidney transplantation and islet cell transplantation for diabetes, eGenesis has raised over $265 million in funding and employs 51-200 professionals dedicated to transforming transplantation medicine and providing scalable solutions for patients suffering from end-stage organ failure.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.